Drug
Standardized Senna Concentrate And Docusate Sodium
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Pulmonary Mass | 14 | 14.3 | 14.5 | signal |
| 2 | Atelectasis | 9 | 14.1 | 14.2 | signal |
| 3 | Hypercalcaemia | 11 | 13.6 | 13.7 | signal |
| 4 | Iron Deficiency Anaemia | 7 | 11.6 | 11.6 | signal |
| 5 | Acute Respiratory Failure | 14 | 11.1 | 11.2 | signal |
| 6 | Febrile Neutropenia | 47 | 10.8 | 11.1 | signal |
| 7 | Intervertebral Disc Degeneration | 6 | 9.8 | 9.8 | signal |
| 8 | Arteriosclerosis | 6 | 9.7 | 9.7 | signal |
| 9 | Metastases To Central Nervous System | 8 | 9.5 | 9.5 | signal |
| 10 | Oral Pain | 14 | 9.5 | 9.6 | signal |
| 11 | Blood Calcium Decreased | 7 | 9.4 | 9.5 | signal |
| 12 | Metastases To Bone | 10 | 9.3 | 9.4 | signal |
| 13 | Pericardial Effusion | 14 | 9.2 | 9.3 | signal |
| 14 | Pleural Effusion | 37 | 9.2 | 9.5 | signal |
| 15 | Metastases To Lung | 7 | 9.2 | 9.3 | signal |
| 16 | Acute Myeloid Leukaemia | 9 | 8.8 | 8.8 | signal |
| 17 | Mental Status Changes | 16 | 8.8 | 8.8 | signal |
| 18 | Osteomyelitis | 10 | 8.4 | 8.5 | signal |
| 19 | Dental Caries | 6 | 8.3 | 8.3 | signal |
| 20 | Plasma Cell Myeloma | 21 | 8.2 | 8.3 | signal |
| 21 | Red Blood Cell Count Decreased | 15 | 8.0 | 8.0 | signal |
| 22 | Full Blood Count Decreased | 10 | 7.5 | 7.6 | signal |
| 23 | Spinal Operation | 6 | 7.5 | 7.6 | signal |
| 24 | Kidney Infection | 9 | 7.0 | 7.0 | signal |
| 25 | Metastases To Liver | 8 | 6.9 | 7.0 | signal |
| 26 | Posterior Reversible Encephalopathy Syndrome | 4 | 6.4 | 6.4 | signal |
| 27 | Cytokine Release Syndrome | 8 | 6.4 | 6.4 | signal |
| 28 | Laceration | 4 | 6.4 | 6.4 | signal |
| 29 | Therapy Partial Responder | 6 | 6.1 | 6.1 | signal |
| 30 | Malignant Neoplasm Progression | 40 | 6.0 | 6.1 | signal |
| 31 | Lung Infection | 6 | 5.8 | 5.8 | signal |
| 32 | Bone Loss | 5 | 5.0 | 5.0 | signal |
| 33 | Blood Thyroid Stimulating Hormone Increased | 3 | 4.9 | 4.9 | signal |
| 34 | Muscle Spasticity | 4 | 4.9 | 4.9 | signal |
| 35 | Osteonecrosis Of Jaw | 8 | 4.9 | 4.9 | signal |
| 36 | Hair Colour Changes | 4 | 4.8 | 4.8 | signal |
| 37 | Parkinsonism | 3 | 4.7 | 4.7 | signal |
| 38 | Complication Associated With Device | 4 | 4.6 | 4.6 | signal |
| 39 | Central Nervous System Lesion | 4 | 4.4 | 4.4 | signal |
| 40 | Neoplasm Progression | 10 | 4.3 | 4.4 | signal |
| 41 | Breast Cancer Metastatic | 3 | 4.2 | 4.3 | signal |
| 42 | Madarosis | 3 | 3.9 | 3.9 | no signal |
| 43 | Prostatic Specific Antigen Increased | 3 | 3.3 | 3.3 | no signal |
| 44 | Palmar-plantar Erythrodysaesthesia Syndrome | 5 | 3.2 | 3.3 | signal |
| 45 | Glycosylated Haemoglobin Increased | 5 | 3.0 | 3.0 | signal |
| 46 | Device Failure | 3 | 3.0 | 3.0 | no signal |